Source author record

M. P. Calatayud

M. P. Calatayud appears in the imported research catalog. Authorship, coauthor and topic links are available while profile ownership is still unclaimed.

ResearcherUnclaimed source record

Tissues and Organs Biological Physics cond-mat.mtrl-sci cond-mat.soft physics.chem-ph physics.med-ph Subcellular Processes

Catalog footprint

What is connected

3works

7topics

4close collaborators

Actions

Connect this record

Open graph Browse works

Inspect adjacent papers, topics, institutions and collaborators without losing the researcher page.

Building this map preview

BZPEER is loading the nearby papers, people, topics and institutions for this page.

preprint2016arXiv

Long term stability and reproducibility of magnetic colloids are key issues for steady values of Specific Power Absorption through time

Virtually all clinical applications of magnetic nanoparticles (MNPs) require the formulation of biocompatible, water-based magnetic colloids. For magnetic hyperthermia, the requirements also include a high colloidal stability against precipitation and agglomeration of the constituent MNPs, in order to keep the heating efficiency of the ferrofluid in the long term. The specific power absorption (SPA) of single-domain MNPs depends critically on the average particle size and size distribution width, therefore first-rate reproducibility among different batches regarding these parameters are also needed. We have studied the evolution of the SPA of highly reproducible and stable water-based colloid composed of polymer coated $Fe_{3}O_{4}$ magnetic nanoparticles. By measuring the specific power absorption (SPA) values along one year as a function of field amplitude and frequencies ($H \leq 24 kA/m$; $260 \leq f \leq 830 kHz$), we demonstrated that SPA in these samples can be made reproducible between successive synthesis, and stable along several months, due to the in situ polymer coating that provides colloidal stability and keeps dipolar interactions negligible.

preprint2015arXiv

Cell bystander effect induced by radiofrequency electromagnetic fields and magnetic nanoparticles

Induced effects by direct exposure to ionizing radiation (IR) are a central issue in many fields like radiation protection, clinic diagnosis and oncological therapies. Direct irradiation at certain doses induce cell death, but similar effects can also occur in cells no directly exposed to IR, a mechanism known as bystander effect. Non-IR (radiofrequency waves) can induce the death of cells loaded with MNPs in a focused oncological therapy known as magnetic hyperthermia. Indirect mechanisms are also able to induce the death of unloaded MNPs cells. Using in vitro cell models, we found that colocalization of the MNPs at the lysosomes and the non-increase of the temperature induces bystander effect under non-IR. Our results provide a landscape in which bystander effects are a more general mechanism, up to now only observed and clinically used in the field of radiotherapy.

preprint2012arXiv

Novel multifunctional 90Y-labelled albumin magnetic microspheres for cancer therapy

We present in vitro and in vivo studies of yttrium-90 (90Y)-labelled human serum albumin magnetic microspheres (HSAMMS) as multifunctional agent for bimodal radionuclide-hyperthermia cancer therapy. The HSAMMS were produced using a modified emulsification-heat stabilization technique and contained 10-nm magnetite nanoparticles coated with citric acid, distributed as inhomogeneous clusters within the albumin microspheres. The average particle size of the complete HSAMMS was 20 (mu)m, and they exhibited superparamagnetic behavior at room temperature. The stability of the 90^Y-labelled HSAMMS was investigated in vitro (in saline and human serum) and in vivo by analyzing their biodistribution in normal Wistar rats. The in vitro experiments revealed the high stability of the labelled HSAMMS in saline and human serum after 72 h. Following the intravenous administration of the 90^Y-HSAMMS in rats, 88.81% of the activity localizes in the lungs after 1 h, with 82.67% remaining after 72 h. These data on 90Y-HSAMMS provide good evidence for their potential use in bimodal radionuclide-hyperthermia cancer therapy.